Global Stoma/Ostomy Care Market Report 2021: Market to Reach $4 1 Billion by 2026 - Product Innovations and Advancements to Spur Market Expansion prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
To embed, copy and paste the code into your website or blog:
In Week 12, the Iowa Legislature passed through the second funnel and Rita Hart dropped her contest of the election results. The Governor has signed over three dozen bills.
The close of the twelfth week brought the close of the second legislative funnel. This legislative milestone narrows the policy discussion for the remainder of session. Going forward, only bills that have advanced through one chamber and through committee in the opposite chamber can be considered in addition to appropriations bills and ways and means bills. Effectively, committee work on policy has come to completion for the legislative session. Senate committees will continue to meet to consider Governor appointments, though that work is slated to be completed by the end of week 14 (April 15).
Pomerantz LLP is investigating claims on behalf of investors of iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ: IRTC). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ: IRTC) from August 4, 2020 and January 28, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934. If you purchased iRhythm securities, and/or would like to discuss your legal rights and options please visit iRhythm Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com The complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose to investors that: (1) iRhythm's business would
NEW YORK, NY / ACCESSWIRE / February 13, 2021 / Pomerantz LLP is investigating claims on behalf of investors of iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ:IRTC).